Heart · 1992 · 26 citations · 16 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyPulmonologyBalloon AngioplastyCardiac Valve SurgeryCongenital Heart DiseaseHeart FailureSurgical Valve ReplacementTricuspid RegurgitationCarcinoid Heart DiseaseCardiac OutputCongenital Pulmonary StenosisPulmonary Valve StenosisReduced Cardiac OutputSecondary Tricuspid RegurgitationSymptomatic TherapyTricuspid Stenosis
BACKGROUND: Carcinoid heart disease typically results in pulmonary stenosis and tricuspid incompetence. Percutaneous balloon dilatation is an effective treatment for congenital pulmonary stenosis and has been applied successfully to tricuspid stenosis caused by carcinoid heart disease. The value of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis was assessed. METHODS: Two patients with severe congestive heart failure secondary to carcinoid heart disease and with documented pulmonary stenosis had balloon dilatation of the pulmonary valve. In both cases tricuspid regurgitation was also present together with reduced cardiac output. RESULTS: The procedure was technically successful in both patients. One patient experienced symptomatic benefit for two months and the other experienced no improvement. Both patients subsequently required combined tricuspid and pulmonary valve replacement from which good results and symptomatic improvement were obtained. CONCLUSION: Though balloon dilatation of the pulmonary valve is technically feasible it is unlikely to provide useful palliation in carcinoid heart disease. Valve surgery should be considered in patients in whom the malignancy is controlled but carcinoid heart disease is producing drug resistant congestive heart failure.
16
Treatment of the Malignant Carcinoid Syndrome
Larry K. Kvols, Charles G. Moertel, Michael J. O’Connell et al. · New England Journal of Medicine · 1986 · 850 citations
Åke Thorson, Gunnar Biörck, Gunnat Björkman et al. · American Heart Journal · 1954 · 538 citations
Medicine, Cardiology, Oncology +17
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
Kjell Öberg, Ingrid Norheim, Evan Lind et al. · PubMed · 1986 · 164 citations
Medicine, Oncology, Pharmacology +10